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ABStrACt
Nisamalaki Churna is an Ayurveda formulation used for diabetes, which consists of amalaki and haridra. in vitro 
antidiabetic screening of Nisamalaki Churna by α-amylase inhibition was carried out by starch iodine method, 
dinitrosalicylic acid method (DNSA) and effect on normal rats blood sugar level was studied. Nisamalaki Churna shows 
potent α-amylase inhibition IC50 89.44 µg/mL by starch iodine method and IC50100.0 µg/mL by DNS method. Nisamalaki 
Churna showed potent decrease in blood glucose level in normal rats.
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ABStrAk
Nisamalaki Churna adalah formula Ayurveda untuk diabetis yang mengandungi amalaki dan haridra. Penyaringan 
antidiabetis in vitro Nisamalaki Churna telah dijalankan. Kesan Nisamalaki Churna terhadap perencatan α-amilase 
telah dikaji menggunakan kaedah iodin kanji. Dengan menggunakan kaedah asid dinitrosalisilik (DNSA) kesan terhadap 
aras gula dalam darah tikus biasa telah dijalankan. Nisamalaki Churna menunjukkan kesan perencatan α-amilase 
yang kuat, IC50 89.44 µg/mL melalui kaedah iodin kanji dan IC50100.0 µg/mL DNS. Nisamalaki Churna menunjukkan 
penurunan aras glukos yang kuat dalam tikus biasa. 
Kata kunci: Nisamalaki Churna; penyaringan antidiabetis; perencatan α-amilase 
iNtroduCtioN
india has a rich heritage of traditional medicine constituting 
with its different components like Ayurveda, Siddha 
and Unani. Botanicals constitute a major part of these 
traditional medicines. Nisamalaki Churna is an Ayurveda 
formulation which is used for antidiabetic, consists of 
fine powders of Turmeric (haridra) – Curcuma longa – 1 
part and Emblica (amalaki) – Emblica officinalis – 1 part 
(Anon. 2000).
 Curcuma longa (Zingeberaceae) has been used as 
spice and coloring agent. Sushruta recommended it for 
epilepsy and bleeding disorders. Charaka recommends it 
for skin diseases, to purify the body mind and to help the 
lungs expel kapha. in Ayurveda, the traditional indian 
system of medicine, it has been used in several ways 
namely as an ingredient in the preparation of medicinal 
oils, ointment and poultice, in diabetes and leprosy, for 
stomachache, carminative, tonic, laxative, antirheumatic, 
blood purifier, vermicide, antiseptic and cure for liver 
ailments. the raw juice is used to relief gall bladder 
complaints, dental-troubles, sore throat, common cold, 
parasitic skin diseases and pile cure. turmeric helps 
regulate the female reproductive system and purifies the 
uterus and breast milk and in men it purifies and builds 
semen (Chandrashekhara & Srinivasan 1999; Gururaj et 
al. 2002).
 Emblica officinalis (euphorbiaceae) known as Amla 
and indian Gooseberry’ is the richest known source of 
vitamin C. Amalaki is native to india and Southeast 
Asia and is one of the most revered rejuvenative tonics 
of ayurvedic medicine. Amalaki is full of powerful 
antioxidants that protect cells against free-radical 
damage, acting as an ‘anti-aging’ tonic super food. it 
is nicknamed dhatri, or ‘the nurse’ for its renowned 
ability to nurture us back to vibrant health. According to 
Ayurveda, amalaki is cooling in energy, predominantly 
sour in taste and has a sweet ‘post-digestive effect’ 
(acts as an overall tonic). it is especially recognized as 
a detoxifier and rejuvenative tonic for people suffering 
from excess heat conditions such as hyperacidity, 
heartburn, infections, inflammations, bleeding disorders, 
liver problems, skin disorders and biliousness. in 
addition, it is often recommended for colds, to improve 
eyesight, to strengthen the bones and for all signs of 
premature aging (dey 1980; Naveen 1993). the present 
investigation was to confirm the antidiabetic activity of 
Nisamalaki Churna.
MAteriAlS ANd MethodS
prepArAtioN oF NiSAMAlAki ChurNA
Curcuma longa (10 g) and Embolic officinalis (10 g) are 
finely powdered and passed through 100 No. sieve and 
mixed. Nisamalaki Churna was extracts with distilled water 
and the extract is dried.
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IN VITro AlphA AMylASe iNhiBitioN ASSAy
3, 5-Dinitrosalicylic acid method (DNSA)   the inhibition 
assay was performed according to Miller (1959) using 
dNS method. Aqueous extract of Nisamalki churna of 
varied concentrations in 500 μL were added to 500 μL 
of 0.02 M sodium phosphate buffer (ph6.9 containing 6 
mM sodium chloride) containing 0.04 units of α-amylase 
solution and were incubated at 37°C for 10 min, followed 
by addition of 500 μL of a 1% starch solution in 0.02 M 
sodium phosphate buffer (ph6.9) all the test tubes. the 
reaction was stopped with 1.0 ml of 3, 5 dNSA reagent. the 
test tubes were then incubated in a boiling bath water for 5 
min and cooled to room temperature. the reaction mixture 
was then diluted after adding 10 ml distilled water and 
absorbance was measured at 540 nm. the control samples 
were also prepared accordingly without any plant extracts 
and were compared with the test samples containing 
various concentrations of the plant extracts prepared 
with different solvents. The results were expressed as % 
inhibition calculated using the formula: 
 
                                      Abs (Control)-Abs (extract) × 100 % Inhibition activity = ______________________  
        Abs (Control)
.
Starch-iodine Colour Assay   Screening of Nisamalaki 
Churna for α-amylase inhibitors was carried out according 
to Xiao et al. (2006) with slight modification based on the 
starch-iodine test. Aqueous extract of Nisamalki churna 
of varied concentrations in 500 μL were added to 500 μL 
of 0.02 M sodium phosphate buffer (ph6.9 containing 6 
mM sodium chloride) containing 0.04 units of α-amylase 
solution and were incubated at 37°C for 10 min. then 500 
μL soluble starch (1%, w/v) was added to each reaction 
well and incubated at 37°C for 15 min. 1 M HCl (20 μL) 
was added to stop the enzymatic reaction, followed by 
the addition of 100 μL of iodine reagent (5 mM I2 and 5 
mM ki). the colour change was noted and the absorbance 
was read at 620 nm on a microplate reader. the control 
reaction representing 100% enzyme activity did not contain 
any plant extract. to eliminate the absorbance produced 
by plant extract, appropriate extract controls without the 
enzyme were also included. inhibition of enzyme activity 
was calculated as:
 Inhibition of enzyme activity (%) = (C-S) / C × 100,
where S is the absorbance of the sample and C is the 
absorbance of blank (no extract).
ANiMAlS
Male Wistar rats weighing 150-250 g were acclimatized to 
the experimental room at temperature 23 ± 2°C, controlled 
humidity conditions (50-55%) and 12 h light and 12 h dark 
cycle. they were caged with a maximum of two animals 
in polypropylene cage and were fed with standard food 
pellets (kamadenu enterprises, Bangalore) and water ad 
libitum. All the studies conducted were approved by the 
institutional animal ethical committee of Sri k.V. College 
of pharmacy, Chickballapur, karnataka, according to 
prescribed guidelines of CpCSeA, Government of india 
(Reg. No. 117/2000/CpCSeA).
ANtidiABetiC SCreeNiNG iN NoN-FASted rAtS
prior to the study, blood samples were collected from all 
the animals to check random glucose levels. the animals 
which had a glucose level >130 gm/dL were excluded from 
the study. Five groups of non-fasted rats, six in each were 
grouped as follows:
 Group I – Control (0.5% w/v CMC) administered;
 Group ii – Glucose control ;
 Group iii – Standard drug treatment (metformin- 
250 mg/kg, p.o.);
 Group IV – Nisamalaki Churna (90 mg/kgp.o.)
 Group V – Nisamalaki Churna (180 mg/kgp.o.)
 the test and standard substances were suspended in 
0.5% w/v carboxy methyl cellulose (CMC). Group ii to 
group V animals were given 5 g/kg glucose additionally 
after 30 min of standard drug/ test substance administration. 
Blood samples were collected from retrooribatal puncture 
for glucose estimation at various time points like pre dose, 
1.0, 2.0, 3.0 and 4.0 h after test substance/ standard drug 
treatment. Glucose was estimated by using lab-india auto-
analyzer with the help of lab kit enzymatic kit (Nyunai 
2006; Vogel 2002).
StAtiStiCAl ANAlySiS
the values were expressed as mean ± SeM (n=5) for each 
group. The significant difference between groups was 
determined using one-way ANoVA followed by dunett’s 
test. P value less than 0.05 was considered significant.
reSultS ANd diSCuSSioN
IN VITro α-AMylASe iNhiBitioN ASSAy oF 
NiSAMAlAki ChurNA
drugs that inhibit carbohydrate hydrolyzing enzymes have 
been demonstrated to decrease postprandial hyperglycemia 
and improve impaired glucose metabolism without 
promoting insulin secretion of NiddM patients. the results 
of in vitro studies showed that Nisamalaki Churna inhibits 
α-amylase activity. Natural health products of vegetable 
origin were clearly indicated as a promising avenue for 
the prevention of chronic diseases (punitha & Manoharan 
2006). Figures 1 and 2 show that Nisamalaki Churna 
significant inhibition of α-amylase enzyme. IC50 values 
of Nisamalaki Churna by dNSA and Starch iodine method 
were 89.44 and 100.0 μg/mL, respectively.
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FiGure 1. Effect of Nisamalaki Churna on α-amylase inhibition activity 
by Starch iodine method
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FiGure  2. Effect of Nisamalaki Churna on α-amylase 
inhibition activity by dNS method
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FiGure  3. effect of Nisamalaki Churna on blood glucose levels of non fasted rats
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ANtidiABetiC SCreeNiNG iN NoN-FASted rAtS
the oral hypoglycaemic effect of Nisamalaki Churna was 
studied in non-fasted Wistar rats. the Nisamalaki Churna 
significantly reduced (p< 0.05 – 0.01) hyperglycemia at the 
dose levels of 90 and 180 mg/kg, compared with glucose 
treated group (group-2). the glucose control group showed 
significant (p< 0.01) increase in glucose levels after 30 
min of glucose administration in all the animals when 
compared with normal group animals. the hypoglycemic 
effect of Nisamalaki Churna comparably equivalent to the 
standard metformin (Figure 3). the results of this study 
indicated that Nisamalaki Churna showed appreciable 
antidiabetic activity. this study supports the ayurvedic use 
of Nisamalaki Churna. 
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